With a 90% Win Rate, Did You Participate in the 2024 IPOs? | 2024 Bursa IPO Recap
Pharming's Phase III Study Highlights Leniolisib's Potential To Transform Treatment For Pediatric APDS Patients (Ages 4-11)
Malaysia Morning Wrap | SNS has reported a five-fold rise in its 3QFY25 net profit to RM10.2mn from RM2.0n a year earlier
Malaysia Morning Wrap | Hibiscus Petroleum Faces Sharp Decline in Profits Due to Asset Shutdowns and Market Conditions
Express News | AZAMJAYA Continues to Rise on Its Second Day of Listing, Soaring by 10% to RM1.2, With a Turnover of RM37.35 Million.
Gamuda Receives "Buy" Rating from MIDF Research with Target Price of RM9.64